ACC.26丨5場(chǎng)特色臨床研究引領(lǐng)精準(zhǔn)診療新風(fēng)向，勾勒心血管精準(zhǔn)治療新圖景

北京時(shí)間3月28日至30日，由美國(guó)心臟病學(xué)會(huì)（ACC）舉辦的心血管領(lǐng)域盛會(huì)——ACC.26學(xué)術(shù)會(huì)議將在美國(guó)新奧爾良隆重舉行。本次為期3天的會(huì)議亮點(diǎn)滿滿，設(shè)有7場(chǎng)最新突破性臨床試驗(yàn)（Late-Breaking Clinical Trials）、5場(chǎng)特色臨床研究（Featured Clinical Research）等多場(chǎng)精彩會(huì)議，將公布眾多前沿臨床研究成果。其中，來(lái)自中國(guó)人民解放軍東部戰(zhàn)區(qū)總醫(yī)院的唐春香教授與郭翔教授、中國(guó)醫(yī)學(xué)科學(xué)院阜外醫(yī)院的康連鳴教授將分別報(bào)告其團(tuán)隊(duì)在冠狀動(dòng)脈疾病無(wú)創(chuàng)評(píng)估、人群篩查及心肌病治療領(lǐng)域的前沿成果，展現(xiàn)中國(guó)心血管臨床研究的深度與廣度。目前官網(wǎng)日程已發(fā)布，POCKETIN對(duì)FCR專場(chǎng)日程進(jìn)行詳細(xì)整理，一起先睹為快！

Featured Clinical Research I

北京時(shí)間：3月29日 02:00-03:00

A Prospective Multicenter Registry to Define Coronary Vasomotor Disorders in Ischemia With Nonobstructive Coronary Arteries: Primary Results of Discover Inoca
一項(xiàng)前瞻性多中心注冊(cè)研究旨在明確非阻塞性冠狀動(dòng)脈缺血中的冠狀動(dòng)脈血管舒縮功能障礙：DISCOVER INOCA研究主要結(jié)果
Samit M. Shah
Impact of Ivabradine on Orthostatic Intolerance, Quality of Life and Heart Rate in Post-Covid Postural Orthostatic Tachycardia Syndrome: Results From the Recover-Autonomic Trial
伊伐布雷定對(duì)新冠后體位性心動(dòng)過速綜合征患者直立不耐受、生活質(zhì)量及心率的影響：RECOVER-AUTONOMIC試驗(yàn)結(jié)果
Saibal Kar Coronary Optical Coherence Tomography and Cardiac Magnetic Resonance Imaging to Determine Sex Differences in Underlying Causes of Myocardial Infarction With No Obstructive Coronary Arteries
應(yīng)用冠脈光學(xué)相干斷層掃描與心臟磁共振成像探究非阻塞性冠脈心肌梗死病因的性別差異
Harmony R. Reynolds A Sham Controlled Randomised Trial Evaluating the Safety, Acceptability and Efficacy of Autonomic Neuromodulation Using Trans-Cutaneous Vagal Sensory Stimulation in Uncontrolled Hypertensive Patients
評(píng)估經(jīng)皮迷走神經(jīng)感覺刺激用于未控制高血壓患者自主神經(jīng)調(diào)節(jié)的安全性、可接受性與有效性：一項(xiàng)假刺激對(duì)照隨機(jī)試驗(yàn)
Ajay K. Gupta

Featured Clinical Research II

北京時(shí)間：3月29日 03:30-04:30

Effects of Tirzepatide Compared With Dulaglutide on Expanded Cardiorenal Outcomes
替西帕肽對(duì)比度拉糖肽對(duì)擴(kuò)展心腎結(jié)局的影響

Steven E. Nissen

Prevalence and Clinical Impact of Hypercortisolism in Individuals With Resistant Hypertension: Primary Results From the Momentum Study
難治性高血壓患者中皮質(zhì)醇增多癥的患病率與臨床影響：MOMENTUM研究的主要結(jié)果
Deepak L. Bhatt Reliability of CAC=0 to Exclude Coronary Plaque in Diverse Global Cohorts: A Global Probability Study of Coronary Artery Disease (GPS-CAD) Analysis
CAC=0在不同種族隊(duì)列中排除冠脈斑塊的可靠性評(píng)估：全球冠狀動(dòng)脈疾病概率研究（GPS-CAD）數(shù)據(jù)分析
Lohendran Baskaran
Community-to-Clinic Linkage Implementation Program to Prevent Hypertension in Barbershops
基于理發(fā)店的社區(qū)-診所聯(lián)動(dòng)高血壓預(yù)防計(jì)劃實(shí)施研究

Joseph E. Ravenell

Featured Clinical Research III

北京時(shí)間：3月30日 02:15-03:15

10-year Follow-up of Clopidogrel Vs Aspirin Monotherapy in Stable Coronary Artery Disease After Percutaneous Coronary Intervention With Drug-eluting Stent
藥物洗脫支架經(jīng)皮冠狀動(dòng)脈介入治療后，氯吡格雷對(duì)比阿司匹林單藥治療穩(wěn)定型冠狀動(dòng)脈疾病的10年隨訪
Hyo-Soo Kim
Coronary CT Derived Fractional Flow Reserve-guided Management of Patients With Stable CAD: 3-year Outcomes From A Multicentre, Pragmatic, Open-label, Randomised Controlled Trial in China
冠狀動(dòng)脈CT衍生的血流儲(chǔ)備分?jǐn)?shù)指導(dǎo)的穩(wěn)定型冠狀動(dòng)脈疾病患者管理：一項(xiàng)中國(guó)多中心、實(shí)用性、開放標(biāo)簽、隨機(jī)對(duì)照試驗(yàn)的3年結(jié)果
唐春香 中國(guó)人民解放軍東部戰(zhàn)區(qū)總醫(yī)院 Role of Screening With Coronary Computed Tomography Angiography in Lipid Management in an Asymptomatic Chinese Population: A Community-Based, Parallel-Group, Open-Label, Randomized Clinical Trial (RESPECT2)
冠狀動(dòng)脈CT血管造影篩查在無(wú)癥狀中國(guó)人群血脂管理中的作用：一項(xiàng)基于社區(qū)的、平行組、開放標(biāo)簽、隨機(jī)臨床試驗(yàn)（RESPECT2）
郭翔 中國(guó)人民解放軍東部戰(zhàn)區(qū)總醫(yī)院
Targeted Assessment in High-Risk Patients With Diabetes to Identify Undiagnosed Heart Failure
對(duì)高風(fēng)險(xiǎn)糖尿病患者進(jìn)行針對(duì)性評(píng)估以識(shí)別未確診的心力衰竭

Daniel Taylor-Sweet

Featured Clinical Research IV

北京時(shí)間：3月30日 03:45-04:45

Automated Notifications to Improve Referral and Treatment of Severe Aortic Stenosis and Mitral Regurgitation: Outcomes From the Randomized Alert Trial
自動(dòng)化通知改善重度主動(dòng)脈瓣狹窄和二尖瓣反流的轉(zhuǎn)診與治療：隨機(jī)ALERT試驗(yàn)的結(jié)果
Wayne B. Batchelor
A Randomized Controlled Trial of a Novel Just-in-Time Adaptive Mobile Application Intervention to Reduce Sodium Intake and Blood Pressure in Patients With Hypertension
一項(xiàng)關(guān)于新型即時(shí)適應(yīng)性移動(dòng)應(yīng)用程序干預(yù)以降低高血壓患者鈉攝入和血壓的隨機(jī)對(duì)照試驗(yàn)

Michael Dorsch

NOTIFY-HF: A Randomised Pilot Trial of Patient-Facing Heartlogic Alerts in Heart Failure Patients
NOTIFY-HF：一項(xiàng)面向心力衰竭患者的HeartLogic警報(bào)的隨機(jī)試點(diǎn)試驗(yàn)
Joseph Assad
MUTTON-HF (Medically Utilized Tailored Traditional Foods to Optimize Nutrition in Heart Failure): A Randomized Controlled Trial of an Indigenous Food is Medicine Intervention
MUTTON-HF（醫(yī)療化應(yīng)用定制傳統(tǒng)食物以優(yōu)化心力衰竭營(yíng)養(yǎng)）：一項(xiàng)本土食物即藥物的干預(yù)措施隨機(jī)對(duì)照試驗(yàn)
Lauren A. Eberly

Featured Clinical Research V

北京時(shí)間：3月30日 6:00-7:00

Two-Year Outcomes of Transcatheter Tricuspid Valve Replacement For Severe Tricuspid Regurgitation: The TRISCEND II Randomized Trial
經(jīng)導(dǎo)管三尖瓣置換治療重度三尖瓣反流的兩年結(jié)果：TRISCEND II 隨機(jī)試驗(yàn)

Vinod H. Thourani

Efficacy and Safety of BHB/HRS-1893 in Symptomatic Obstructive Hypertrophic Cardiomyopathy: Results From A 12-week Phase 2 Study

BHB/HRS-1893在有癥狀的梗阻性肥厚型心肌病中的療效與安全性：一項(xiàng)為期12周的2期研究結(jié)果

康連鳴 中國(guó)醫(yī)學(xué)科學(xué)院阜外醫(yī)院

The Role of Atrial Pacing Support in Cardiac Resynchronization Therapy: A Non-inferiority Randomized Trial
心房起搏支持在心臟再同步化治療中的作用：一項(xiàng)非劣效性隨機(jī)試驗(yàn)
Mauro Biffi
Prehospital Heparin Administration in Patients With STEMI Undergoing Primary PCI
行直接經(jīng)皮冠狀動(dòng)脈介入治療的STEMI患者的院前肝素給藥
Misa Fister

POCKETIN 將挑選重點(diǎn)研究，就已發(fā)布結(jié)果邀請(qǐng)專家陸續(xù)解讀

POCKETIN接受投稿，我們將為撰稿作者提供該研究的過往詳細(xì)資料，資料包括：原文、演講幻燈、官方新聞、演講視頻等素材。并根據(jù)稿件質(zhì)量支付稿費(fèi)。

稿件將發(fā)表在POCKETIN、心關(guān)注微信公眾號(hào)上，并發(fā)表在國(guó)際期刊《翳望》（ISSN 2709-9105）上。同時(shí)，稿件將作為供稿提供給合作單位。

投稿請(qǐng)聯(lián)系：zhengsisi@medicaltelescope.cn 鄭思思

如發(fā)現(xiàn)文內(nèi)有誤請(qǐng)聯(lián)系我們

來(lái)源：ACC.26